LIHE MedTech Venture Builder - Applications now open

Closing 12th April – Starting July 2026

The LIHE MedTech Venture Builder (MVB), now in its third year, is a 12-month structured programme in two stages to speed-up the commercial and clinical translation of promising medical technologies into robust, investment-ready healthcare ventures.

Supporting companies from across the UK, the MVB, the first of its kind, is a collaborative effort led by LIHE (London Institute for Healthcare Engineering), in collaboration with leading NHS Trusts, industrial partners, prominent charities, and select impact investors.

The MedTech Venture Builder programme is structured in two stages: Foundation and Execution, both focusing on key translational elements but at different depths.

The Foundation stage is free to join for eligible participants.

At the end of Foundation, select companies will be invited to join the Execution stage, where they will receive one-to-one, bespoke support.

Key outcomes

By participating in the MedTech Venture Builder your venture will:

• Have moved to its next value inflection point in commercial and clinical terms
• Have validated and strengthened its technology's commercial viability
• Have systematically advanced towards being a compliant, investment-ready healthcare venture
• Have developed core skills in following rigorous MedTech processes
• Have completed a regulatory plan and critical documentation under a Quality Management System
• Have de-risked your proposition for investment, making you investment-worthy
• Have expanded contacts with industry partners and investors

To find out more (including minimum requirements to apply and eligibility), visit the LIHE website.